Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 1,429 | 1,415 | 1,649 |
| Receivables | 336 | 332 | 273 |
| TOTAL | $1,889 | $1,768 | $1,990 |
| Non-Current Assets | |||
| TOTAL | $0 | $0 | $N/A |
| Total Assets | $1,889 | $1,769 | $1,990 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 500 | 202 | 589 |
| TOTAL | $500 | $202 | $589 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 395 | 424 | 436 |
| TOTAL | $395 | $424 | $436 |
| Total Liabilities | $895 | $626 | $1,025 |
| Shareholders' Equity | |||
| Common Shares | 4,348 | 4,070 | 3,473 |
| Retained earnings | -5,430 | -4,571 | -4,110 |
| Other shareholders' equity | 839 | 432 | 439 |
| TOTAL | $995 | $1,143 | $964 |
| Total Liabilities And Equity | $1,889 | $1,769 | $1,990 |